Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson’s disease

References

• Chapuis S, Ouchchane L, Metz O, et al. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord. 2005;20:224–230.
   PubMed Web of Science ®Google Scholar
• Hardoff R, Sula M, Tamir A, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord. 2001;16:1041–1047.
   PubMed Web of Science ®Google Scholar
• Olanow CW, Kieburtz K, Odin P, et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 2014;13:141–149.
   PubMed Web of Science ®Google Scholar
• Nyholm D, Odin P, Johansson A, et al. Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson’s disease patients. Aaps J. 2013;15:316–323.
   PubMed Web of Science ®Google Scholar
• Epstein M, Johnson DA, Hawes R, et al. Long-term PEG-J tube safety in patients with advanced Parkinson’s disease. Clin Trans Gastroenterol. 2016;7:e159.
   PubMed Web of Science ®Google Scholar
• Udd M, Lyytinen J, Eerola-Rautio J, et al. Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson’s disease. Brain Behav. 2017;7:e00737.
   PubMed Web of Science ®Google Scholar
• De Fabregues O, Dot J, Abu-Suboh M, et al. Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion. Brain Behav. 2017;7:e00758.
   PubMed Web of Science ®Google Scholar
• Cheron J, Deviere J, Supiot F, et al. The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson’s disease. United European Gastroenterol J. 2017;5:60–68.
   PubMed Web of Science ®Google Scholar
• Fernandez HH, Vanagunas A, Odin P, et al. Levodopa-carbidopa intestinal gel in advanced Parkinson’s disease open-label study: Interim results. Parkinsonism Relat Disord. 2013;19:339–345.
   PubMed Web of Science ®Google Scholar
• Fernandez HH, Standaert DG, Hauser RA, et al. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. Mov Disord. 2015;30:500–509.
   PubMed Web of Science ®Google Scholar
• Lang AE, Rodriguez RL, Boyd JT, et al. Integrated safety of levodopa-carbidopa intestinal gel form prospective clinical trials. Mov Disord. 2016;31:538–546.
   PubMed Web of Science ®Google Scholar
• Virhammar J, Nyholm D. Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience. Ther Adv Neurol Disord. 2017;10:171–187.
   PubMed Web of Science ®Google Scholar
• Sensi M, Cossu G, Mancini F, et al. Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. Parkinsonism Relat Disord. 2017;38:90–92.
   PubMed Web of Science ®Google Scholar
• Slevin JT, Fernandez HH, Zadikoff C, et al. Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: An open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients. J Parkinsons Dis. 2015;5:165–174.
   PubMedGoogle Scholar
• Antonini A, Poewe W, Chaudhuri KR, et al. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. Parkinsonism Relat Disord. 2017;45:13–20.
   PubMed Web of Science ®Google Scholar
• Zulli C, Sica M, Micco RD, et al. Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study. Eur Rev Med Pharmacol Sci. 2016;20:2413–2417.
   PubMed Web of Science ®Google Scholar
• Figueiredo FA, da Costa MC, Pelosi AD, et al. Predicting outcomes and complications of percutaneous endoscopic gastrostomy. Endoscopy. 2007;39:333–338.
   PubMed Web of Science ®Google Scholar
• Crosby J, Duerksen DR. A prospective study of tube- and feeding-related complications in patients receiving long-term home enteral nutrition. Jpen J Parenter Enteral Nutr. 2007;31:274–277.
   PubMed Web of Science ®Google Scholar
• Borkowski S. G tube care: managing hypergranulation tissue. Nursing. 2005;35:24.
   PubMedGoogle Scholar
• Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, et al. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. Wjg. 2014;28:7739–7751.
   Web of Science ®Google Scholar
• Schrag SP, Sharma R, Jaik NP, et al. Complications related to percutaneous endoscopic gastrostomy (PEG) tubes. A Comprehensive Clinical Review. J Gatrointestin Liver Dis. 2007;16:407–418.
   PubMed Web of Science ®Google Scholar
• Chang WK, Hsieh TY. Safety of percutaneous endoscopic gastrostomy in high-risk patienrs. J Gastroenterol Hepatol. 2013;28:118–122.
   PubMed Web of Science ®Google Scholar
• Chang WK, McClave SA, Yu CY, et al. Positioning a safe gastric puncture point before percutaneous endoscopic gastrostomy. Int J Clin Pract. 2007;61:1121–1125.
   PubMed Web of Science ®Google Scholar
• Lynch CR, Fang JC. Prevention and management of complications of percutaneous endoscopic gastrostomy (PEG) tubes. Prac Gastroenterol. 2004;28:66–67.
   Google Scholar
• Attam R, Arain MA, Leslie DB, et al. Endoscopic sutured gastropexy: a novel technique for performing a secure gastrostomy. Gastrointest Endosc. 2014;79:1011–1014.
   PubMed Web of Science ®Google Scholar
• Thornton FJ, Fotheringham T, Haslam PJ, et al. Percutaneous radiologic gastrostomy with and without T-Faster gastropexy: a randomized comparison study. Cardiovasc Intervent Radio. 2002;25:467–471.
   PubMed Web of Science ®Google Scholar
• Okumura N, Tsuji N, Ozaki N, et al. Percutaneous endoscopic gastrostomy with Funada-style gastropexy greatly reduces the risk of peristomal infection. Gastroenterol Rep. 2015;3:69–74.
   Google Scholar
• Tsuboi T, Watanabe H, Funasaka K, et al. Peritonitis after percutaneous endoscopic gastrojejunostomy for levodopa-carbidopa intestinal gel treatment despite concomitant use of gastropexy. Neurol Clin Neurosci. 2018;6:64–66.
   Web of Science ®Google Scholar
• Doede T, Faiss S, Schier F. Jejunal feeding tubes via gastrostomy in children. Endoscopy. 2002;34:539–542.
   PubMed Web of Science ®Google Scholar
• Dam-Larsen S, Darkahi B, Glad A, et al. Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region. Scand J Gastroenterol. 2015;50:1500–1507.
   PubMed Web of Science ®Google Scholar
• Antonini A, Yegin A, Preda C, et al. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes. Parkinsonism Relat Disord. 2015;21:231–235.
   PubMed Web of Science ®Google Scholar
• Merola A, Espay AJ, Romagnolo A, et al. Advanced therapies in Parkinson's disease: long-term retrospective study. Parkinsonism Relat Disord. 2016;29:104–108.
   PubMed Web of Science ®Google Scholar
• Dimofte MG, Porumb V, Nicolescu S, et al. Laparoscopic-assisted percutaneous endoscopic transgastrostomy jejunostomy. Jsls. 2014;18:e2014.00176.
   PubMed Web of Science ®Google Scholar
• Fan AC, Baron TH, Rumalla A, et al. Comparison of direct percutaneous endoscopic jejunostomy and PEG with jejunal extension. Gastrointest Endosc. 2002;56:890–894.
   PubMed Web of Science ®Google Scholar